In total, 331,590 bottles of Cinacalcet tablets manufactured by Dr. Reddy's Laboratories, Inc. have been recalled due to ...

Purpose: The current primary hyperparathyroidism (PHPT) presents as a mild disease. We explored skeletal phenotypes in postmenopausal women affected by PHPT, focusing on fracture prevalence.

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high ...

Dr Reddy’s Laboratories: The company has announced a recall of over 331,000 bottles of Cinacalcet tablets sold in the US.

The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.

Stocks to watch on Monday, November 4, 2024: Indian bourses are preparing for a negative start on Monday, indicated GIFT ...

According to the latest Enforcement Report by the US Food and Drug Administration, Dr Reddy's is recalling the 3,31,590 ...

Dr Reddy’s Laboratories is recalling over 3.3 lakh bottles of a medication used to treat high calcium levels in the blood and ...

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of a medication used to treat high calcium levels in the blood and hyperparathyroidism in the US market due to manufacturing issues.

The recall is due to the 'presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit', it added.